Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 1,189
-1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we prevent the transmission of BRCA mutations?

Women with the BRCA gene mutation have an 80% risk of developing breast or ovarian cancer. Most research...

MyHealthEd

Each child deserves quality comprehensive sexual health education. No child is the same, so why...

Synthesis of a Kidney Cancer Drug

We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...

Backer Badge Funded